Clomiphene more effective than letrozole for achieving pregnancy, NIH funded study finds Bethesda, Maryland–(ENEWSPF)–September 24, 2015. Treatment with clomiphene, a standard therapy for couples with unexplained infertility, results in more live births than treatment with a potential alternative, letrozole, according to a study of more than 900 couples conducted by[Read More…]
Health and Fitness
Drug Policy Alliance Applauds CVS/pharmacy for Being First Chain Pharmacy in California to Make Overdose Antidote Naloxone Available Without a Prescription
SAN FRANCISCO—(ENEWSPF)–September 24, 2015. The Drug Policy Alliance is applauding CVS/pharmacy for being the first chain pharmacy in California to stock and sell the opiate overdose reversal drug naloxone without a prescription. More than 50 CVS/pharmacy stores in California will make the lifesaving drug available to friends and family members[Read More…]
Smoking Linked with Higher Risk of Type 2 Diabetes
Boston, MA ─(ENEWSPF)–September 18, 2015. Current smokers and people regularly exposed to second-hand smoke have a significantly increased risk for type 2 diabetes compared with people who have never smoked, according to a new meta-analysis conducted by researchers from Harvard T.H. Chan School of Public Health, Huazhong University of Science[Read More…]
New Center for American Progress Report Makes Case for Public- and Private-Sector Reforms to Curb Rising Drug Costs
Luillia Van Lanen is seen with some of her prescription medication in her apartment, March 2007, in Madison, Wisconsin. Source: AP/Morry Gash Washington, D.C. —(ENEWSPF)–September 18, 2015. In a new report published today, the Center for American Progress addresses the rising costs of prescription drugs and challenges policymakers to enact[Read More…]
Tick-borne Heartland Virus More Common Than Thought
Chico, California–(ENEWSPF)–September 17, 2015 By: Michaeleen Doucleff It’s called the Heartland virus disease. Since it was first detected in 2009, there have been only nine reported cases in the Midwest, including two deaths. So scientists thought the Heartland virus was limited to a small region. That assumption was wrong. A[Read More…]
Balance Point Invests in Lyme Testing Company IGeneX
WESTPORT, Conn.–(ENEWSPF)–September 17, 2015. Balance Point Capital Partners (“Balance Point”), a private equity fund focused on providing debt and equity capital to lower middle market companies across the U.S. announced today its investment in IGeneX, Inc. (“IGeneX” or the “Company”). Balance Point provided both unitranche debt and preferred equity alongside[Read More…]
City of Chicago, Cook County Partner to Expand Breast Health Services to Uninsured Women
City Investment Will Provide Screening Mammograms for Up to 5,000 Women CHICAGO–(ENEWSPF)–September 17, 2015. Mayor Rahm Emanuel and Cook County Board President Toni Preckwinkle announced yesterday a new partnership between the City of Chicago and Cook County Health & Hospitals System (CCHHS) to expand and improve breast health services available[Read More…]
HHS Hosts 50-state Convening Focused on Preventing Opioid Overdose and Opioid Use Disorder, Takes Important Step to Increase Access to Treatment
Delegates from across the country convene to collaborate, take action on opioid epidemic Washington, DC–(ENEWSPF)–September 17, 2015. Health and Human Services Secretary Sylvia M. Burwell today kicked off a two-day intensive convening of representatives from all 50 states and Washington, DC focused on preventing opioid overdose and opioid use disorder.[Read More…]
FDA Approves New Drug to Treat Schizophrenia and Bipolar Disorder
Silver Spring, Maryland–(ENEWSPF)–September 17, 2015. The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults. “Schizophrenia and bipolar disorder can be disabling and can greatly interfere with day-to-day activities,” said Mitchell Mathis, M.D., director of the Division of Psychiatry Products in[Read More…]
Experimental Ebola Vaccine Regimen Takes New Steps Under HHS Program
Washington, DC–(ENEWSPF)–September 15, 2015. As part of the international effort to develop vaccines that protect against Ebola and similar viruses, the advanced development of an experimental vaccine regimen will take new steps with support from a four-year, $28.5 million agreement between the U.S. Department of Health and Human Services Office[Read More…]
